文献速递咽喉与嗓音

支架成形寡聚体联合自体运动终板表达细胞的再生性注射喉成形术:一项6个月猪研究

Regenerative Injection Laryngoplasty With Scaffold-Forming Oligomer and Autologous Motor Endplate-Expressing Cells: A 6-Month Porcine Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-08-17

该研究在猪单侧声带麻痹模型中,将免疫耐受性支架成形胶原(Oligomer)与自体运动终板表达(MEE)细胞联合注射至麻痹声带,评估6个月内的长期增强与神经肌肉恢复。结果显示注射耐受良好,无异物反应;Oligomer和MEE+Oligomer均产生持续增强,MEE+Oligomer组喉内收肌体积与对侧对照统计学相似,并表现出更好的神经肌肉功能。结论认为该再生注射策略整合结构与生物学机制,可同时改善UVFP后的机械和生理缺陷。

要点

  • Oligomer支架注射耐受良好,无异物反应,可产生持续声带增强。
  • MEE+Oligomer组6个月时喉内收肌体积与对侧对照统计学相似。
  • MEE+Oligomer与更好的神经肌肉功能相关,提示再神经支配改善。

核心结论

  • 在猪UVFP模型中,支架成形Oligomer提供持续、免疫耐受的增强并维持嗓音改善。
  • MEE的加入支持增强的神经肌肉功能,与再神经支配改善一致。

研究设计与样本

  • 去神经支配约1个月后,向麻痹声带注射生理盐水、Oligomer或MEE+Oligomer。
  • 通过视频喉镜和声学发声分析评估6个月结局,并用喉肌电图(L-EMG)和喉内收压力(LAP)评估神经肌肉功能。

主要发现

  • 所有注射均耐受良好,无异物反应证据。
  • Oligomer和MEE+Oligomer产生持续增强,MEE+Oligomer组6个月时喉内收肌体积与对侧对照统计学相似。
  • 两种治疗均改善发声结局,MEE+Oligomer与更好的刺激下声带内收、L-EMG活动和LAP反应相关。
  • 组织学分析显示可识别的支架整合并保留肌肉形态。

临床怎么用

  • 该再生注射喉成形术策略可能为UVFP提供兼具结构增强与生物修复的微创治疗方向。
  • 需进一步临床研究验证其在人体中的长期疗效与安全性。

局限性

  • 研究为猪模型,结果外推至人类需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Injection laryngoplasty is a standard-of-care intervention for unilateral vocal fold paralysis (UVFP), offering minimally invasive medialization with limited durability. We evaluated a regenerative injectable approach integrating an immunotolerant scaffold-forming collagen (Oligomer) with autologous motor-endplate expressing (MEE) cells to support long-term augmentation and neuromuscular recovery. STUDY DESIGN: Porcine UVFP model. SETTING: Translational research laboratory. METHODS: Twelve Yucatan minipigs underwent right recurrent laryngeal nerve transection. Autologous muscle progenitor cells were isolated, differentiated, and induced into MEEs. Approximately 1 month after denervation, Saline, Oligomer, or MEE+Oligomer was injected into the paralyzed vocal fold. Outcomes were assessed through 6 months using videolaryngoscopy and acoustic vocalization analysis. Neuromuscular function was evaluated at baseline and 6 months using laryngeal electromyography (L-EMG) and laryngeal adductor pressure (LAP). Larynges were also harvested for volumetric ultrasound, histology, and gene expression analyses. RESULTS: All injections were well tolerated, with no evidence of foreign body response. Oligomer and MEE+Oligomer produced persistent augmentation, with MEE+Oligomer demonstrating laryngeal adductor muscle volumes statistically similar to contralateral controls at 6 months. Both treatments improved vocalization outcomes, and MEE+Oligomer was associated with greater neuromuscular function, as indicated by improved stimulated vocal fold adduction, L-EMG activity, and LAP responses. Histological analysis demonstrated identifiable scaffold integration with preservation of muscle morphology. CONCLUSION: In a porcine UVFP model, scaffold-forming Oligomer provided persistent, immunotolerant augmentation with sustained voice improvement. MEE incorporation supported enhanced neuromuscular function consistent with improved reinnervation. This regenerative injection laryngoplasty strategy integrates structural and biological mechanisms to address both mechanical and physiological deficits following UVFP.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Sobczak GG, Morrison RA, Zhang L, et al. Regenerative Injection Laryngoplasty With Scaffold-Forming Oligomer and Autologous Motor Endplate-Expressing Cells: A 6-Month Porcine Study. Otolaryngol Head Neck Surg. 2026. PMID: 42606116. doi:10.1002/ohn.70403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。